Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma
Clinical trial NCT06934889 · RECRUITING
Trial details
- NCT number
- NCT06934889
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-07
- Primary completion
- 2028-04-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.